Regulations.gov document
Attachment 3 RLD Label for Naproxen Suspension 25mg/mL re Suitability Petition from Drug…
Supporting & Related Material · FDA-2021-P-0340 · posted Mar 30, 2021
Key facts
| Document ID | FDA-2021-P-0340-0005 |
|---|---|
| Title | Attachment 3 RLD Label for Naproxen Suspension 25mg/mL re Suitability Petition from Drug Device Consulting LLC |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2021-P-0340 |
| Posted | Mar 30, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: